Research Participation

Research plays a key role in shaping our clinical practice at the UCSF Headache Center.

If you interested in participating, please contact Henna Sawhney, MD Clinical Research Coordinator at .(JavaScript must be enabled to view this email address)


1) Long-term observational study to understand disease onset, progression, and determine better treatments for migraine and headache
STUDY TITLE: Prospective cohort study defining the natural history and progression of
PI: Nina Riggins, MD PhD
Sponsor: UCSF Headache Center

2) Randomized controlled trial assessing the efficacy of SPG blocks in the treatment of chronic migraine
STUDY TITLE: Sphenopalatine Ganglion Blocks RCT
PI: Nina Riggins, MD PhD
Sponsor: UCSF Headache Center

3) Assessing if relaxation techniques improve migraine outcomes
STUDY TITLE: Relaxation and Integrative Therapy Techniques in Migraine (RITTIM)
PI: Nina Riggins, MD PhD
Sponsor: UCSF Headache Center

4) Assessing the efficacy of galcanezumab in treating vestibular migraine
STUDY TITLE: A Pilot Trial of Galcanezumab for Vestibular Migraine
PI: Jeffrey Sharon, MD
Sponsor: Eli Lilly & Co.

Not Yet Enrolling - Coming Soon!

1) Long-term study assessing galcanezumab and prophylactic headache treatment
STUDY TITLE: Preventative Treatment of migraine: outcomes for patients in real-world Healthcare systems (TRIUMPH)
PI: Nina Riggins, MD PhD
Sponsor: Lilly

2) Cohort study assessing prodrome symptoms of migraine in patients on ubrogepant
STUDY TITLE: A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Treatment of Migraine When Administered During the Prodrome
PI: Rebecca Michael, MD Sub-I: Sarah Ahmad, MD
Sponsor: Allergan

3) Long-term study assessing cardiovascular safety of fremenezumab and prophylactic treatment

STUDY TITLE: A Long-Term, Prospective, Observational Study to Evaluate the Safety, Including Cardiovascular Safety, of Fremanezumab in Patients with Migraine in Routine Clinical Practice (PASS)
PI: Nina Riggins, MD PhD
Sponsor: Teva

4) Pilot study evaluating treatment of migraine with green light (allay lamp)
STUDY TITLE: Exposure to green light as prophylaxis for migraine headaches
PI: Morris Levin, MD
Sponsor: UCSF Headache Center

5) Pilot study evaluating use of yoga in holistic management of migraine
STUDY TITLE: A pilot study of Yoga for Patients with Migraine
PI: Nina Riggins, MD PhD Sub-I: Sarah Bobker, MD
Sponsor: UCSF Headache Center